Supplemental figure 3 from Efficacy of SERD/SERM Hybrid-CDK4/6 Inhibitor Combinations in Models of Endocrine Therapy–Resistant Breast Cancer
Year: 2023
Type: supplementary-materials
Abstract: Supplemental figure 3: SERDs and palbociclib inhibit breast cancer cell proliferation by independent mechanisms
Authors: Suzanne E. Wardell, Matthew J. Ellis, Holly M. Alley, Koleen Eisele, Todd VanArsdale, Stephen G. Dann, Kim T. Arndt, Tina Primeau, Elizabeth Griffin, Jieya Shao, Robert Crowder, Jin-Ping Lai, John D. Norris, Donald P. McDonnell, Shunqiang Li
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361883489